Skip to main navigation Skip to search Skip to main content

Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial

  • Aditya H. Gaur
  • , James S. McCarthy
  • , John C. Panetta
  • , Ronald H. Dallas
  • , John Woodford
  • , Li Tang
  • , Amber M. Smith
  • , Tracy B. Stewart
  • , Kristen C. Branum
  • , Burgess B. Freeman
  • , Nehali D. Patel
  • , Elizabeth John
  • , Stephan Chalon
  • , Shelley Ost
  • , Ryan N. Heine
  • , Julie L. Richardson
  • , Robbin Christensen
  • , Patricia M. Flynn
  • , Yvonne Van Gessel
  • , Branko Mitasev
    • Jörg J. Möhrle, Fabian Gusovsky, Lidiya Bebrevska, R. Kiplin Guy

Research output: Contribution to journal › Article › peer-review

60   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science